P1.07-023 NGS May Discriminate Extreme Long-Term versus Short-Term Survival in Patients with Stage IV Small-Cell Lung Cancer (SCLC)

Zoltan Lohinai; Balazs Dome; Glen Weiss

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P1.07-023 NGS May Discriminate Extreme Long-Term versus Short-Term Survival in Patients with Stage IV Small-Cell Lung Cancer (SCLC)

【24h】

P1.07-023 NGS May Discriminate Extreme Long-Term versus Short-Term Survival in Patients with Stage IV Small-Cell Lung Cancer (SCLC)

机译：P1.07-023 NGS可能会歧视阶段IV阶段小细胞肺癌（SCLC）患者的极端长期存在的短期存活

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共1页
作者
Zoltan Lohinai; Balazs Dome; Glen Weiss;
展开▼
作者单位

Division of Thoracic Surgery Medical University Vienna;

Department of Tumor Biology National Koranyi Institute of Pulmonology;

Western Regional Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P1.07-023 NGS May Discriminate Extreme Long-Term versus Short-Term Survival in Patients with Stage IV Small-Cell Lung Cancer (SCLC) [J] . Zoltan Lohinai, Balazs Dome, Glen Weiss Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P1.07-023 NGS可能会歧视阶段IV阶段小细胞肺癌（SCLC）患者的极端长期存在的短期存活
2. Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC) [J] . Zoltan Lohinai, Zsolt Megyesfalvi, Balazs Dome, Translational Oncology . 2019,第12期

机译：下一代测序可区分转移性小细胞肺癌（SCLC）患者的极端长期生存与短期生存
3. STUDY15: a multicentre, randomised trial comparing combination gemcitabine/carboplatin and hydroxychloroquine versus carboplatin/etoposide therapy for stage IV small-cell lung cancer (SCLC) [J] . Ngai Y., Hackshaw A., Blackhall F., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第期

机译：研究15：多期式，随机试验比较组合吉西他滨/卡铂和羟基氯喹与卡铂/ Etoposide治疗阶段IV阶段小细胞肺癌（SCLC）
4. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
5. Cost and survival analysis of treating stage IV non-small cell lung cancer. [D] . Folefac, Edmund. 2015

机译：治疗IV期非小细胞肺癌的费用和生存分析。
6. Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC) [O] . Zoltan Lohinai, Zsolt Megyesfalvi, Balazs Dome, 2019

机译：下一代测序可区分转移性小细胞肺癌（SCLC）患者的极端长期生存与短期生存
7. P1.07-023 NGS May Discriminate Extreme Long-Term versus Short-Term Survival in Patients with Stage IV Small-Cell Lung Cancer (SCLC) [O] . Zoltan Lohinai, Balazs Dome, Glen Weiss 2017

机译：P1.07-023 NGS可能会歧视阶段IV阶段小细胞肺癌（SCLC）患者的极端长期存在的短期存活

P1.07-023 NGS May Discriminate Extreme Long-Term versus Short-Term Survival in Patients with Stage IV Small-Cell Lung Cancer (SCLC)

著录项

引文网络

相似文献

相关主题

期刊订阅